Sort
15,273 grants matching “antimicrobial resistance”
Identification of potentiators of antimicrobial activity against multidrug-resistant Burkholderia cepacia complex infections in cystic fibrosis
$262,500Thea Brennan-Krohn · Beth Israel Deaconess Medical Center · R21 · FY2021 · AI
Antimicrobial Lipids within the Oral Cavity
$262,500Philip Wesley Wertz · University Of Iowa · R01 · FY2009 · DE
Methionine sulfoxide reductases and Staphylococcus aureus pathogenesis in the cystic fibrosis lung
$262,500William Norris Beavers · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2024 · GM
Regulation of Pulmonary Host Defenses by the Endoplasmic Reticulum Stress Sensor IRE1α
$262,499Basel Hanna Abuaita · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2025 · GM
Regulation of Pulmonary Host Defenses by the Endoplasmic Reticulum Stress Sensor IRE1α
$262,499Basel Hanna Abuaita · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2024 · GM
The Great Diseases: Bridging biomedical career exploration, competency building and mentoring
$262,488Berri H Jacque · Tufts University Boston · R25 · FY2020 · GM
Containing Bioterroist and Emerging Infectious Diseases
$262,251Fred Hutchinson Cancer Research Center · U01 · FY2005 · GM
Multicenter Trial of Daily Chlorhexidine Bathing to Reduce Nosocomial Infections
$262,214Michael William Climo · Richmond Institute For Veterans Research · U01 · FY2006 · CI
The oral mucosal proteome: perturbation in HIV infection and Candida co infection
$262,170Stephen J Challacombe · King'S College London · R01 · FY2007 · DE
Rapid Comprehensive Identification of Pneumonia Pathogens
$262,052Richard S Ajioka · Biofire Defense, Llc. · R43 · FY2012 · AI
Evolutionary dynamics of non-genetic mechanisms of drug resistance in cancer
$262,000Jasmine Y Foo · University Of Minnesota-Twin Cities · · FY2021 · MPS
Exploiting the Salivary Arsenal to Inhibit Diarrheal Disease
$261,875Esther S. Bullitt · Boston University Medical Campus · R21 · FY2021 · AI
Tobacco Mosaic Virus as a mucosal delivery platform for an intranasal vaccine against Pseudomonas aeruginosa
$261,846Paul Michael Arnaboldi · New York Medical College · R21 · FY2025 · AI
Modeling and Analysis of Bacterial Signaling Circuits
$261,747Mark D Goulian · University Of Pennsylvania · R01 · FY2010 · GM
Task A33: Hamster Model of C. difficile Disease for Testing of Traditional and Non-Traditional Therapeutics
$261,705Saul Tzipori · Tufts University Boston · N01 · FY2021 · AI
Haemophilus Hap-mediated Microcolony Formation
$261,685Joseph W. St. Geme · Duke University · R01 · FY2007 · AI
Targeting DHFR to Design Antimicrobial Agents
$261,494Amy C. Anderson · University Of Connecticut Storrs · R01 · FY2012 · GM
Modeling Membrane Binding and Permeabilization by Antimicrobial Peptides
$261,491Themis Lazaridis · City College Of New York · SC1 · FY2012 · AI
Targeting DHFR to Design Antimicrobial Agents
$261,415Amy C. Anderson · University Of Connecticut Storrs · R01 · FY2011 · GM
The Great Diseases: Bridging biomedical career exploration, competency building and mentoring
$261,408Berri H Jacque · Tufts University Boston · R25 · FY2021 · GM
BACTERIAL PHOSPHORYLCHOLINE AND PATHOGENESIS
$261,401University Of Pennsylvania · R01 · FY2000 · AI
Sustainable One Health Research Training Capacity: Molecular Epidemiology of Zoonotic Foodborne and Waterborne Pathogens in Eastern Africa
$261,131Wondwossen A. Gebreyes · Ohio State University · D43 · FY2017 · TW
VALIDATION OF A HIGH THROUGHPUT SCREEN FOR KPC PLASMID EVICTION
$261,000James E Kirby · Beth Israel Deaconess Medical Center · R21 · FY2016 · AI
Single Antigen Strategy for Prevention of Recurrent and Chronic Suppurative Otitis
$261,000Stephen I. Pelton · Boston Medical Center · R21 · FY2015 · DC
Discovery of fungus-derived natural products as new and effective Antigiardial agents.
$260,648Kayode K Ojo · University Of Washington · R21 · FY2024 · AI